Showing results (121-130 of 446) with videos related to

Sort By:
Pageof 45
Journal of Clinical Neuromuscular Disease|August 20, 2014
Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathyKatherine Ruzhansky, Jacqueline Scoon, Louis H Weimer, et al.
American Heart Journal|November 2, 2013
Posttraumatic stress disorder and risk for coronary heart disease: a meta-analytic reviewDonald Edmondson, Ian M Kronish, Jonathan A Shaffer, et al.
The International Journal of Social Psychiatry|July 3, 2014
Hispanic residential ethnic density and depression in post-acute coronary syndrome patients: Re-thinking the role of social supportEllen-Ge D Denton, Jonathan A Shaffer, Carmela Alcantara, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|July 22, 2015
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)Younhee Cho, Aleksandra Baranczak, Stephen Helmke, et al.
Heart Failure Reviews|March 12, 2015
Cardiac amyloidosis: the great pretenderClaudio Rapezzi, Massimiliano Lorenzini, Simone Longhi, et al.
Blood Reviews|July 4, 2020
The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main typesCindy Varga, Sharmila Dorbala, Isabelle Lousada, et al.
JACC. Heart Failure|March 27, 2026
Screening Strategies for Identification of Transthyretin Amyloid CardiomyopathyAnthony E Peters, Faraz S Ahmad, Trejeeve Martyn, et al.
Journal of the American Heart Association|October 8, 2021
Cardiovascular Diseases That Have Emerged From the DarknessBarry J Maron, Martin S Maron, Mathew S Maurer, et al.
JACC. Cardiooncology|November 3, 2021
ATTR Amyloidosis: Current and Emerging Management Strategies: JACC: CardioOncology State-of-the-Art ReviewJan M Griffin, Julie L Rosenthal, Justin L Grodin, et al.
Congestive Heart Failure (Greenwich, Conn.)|November 25, 2010
Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failureHannah Rosenblum, Stephen Helmke, Paula Williams, et al.
Pageof 45